Gilead Sciences, Inc. (GILD)
150.11
-1.06
(-0.70%)
USD |
NASDAQ |
Oct 12, 12:01
Gilead Sciences Profit Margin (Quarterly) : -134.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -134.2% |
| March 31, 2026 | 28.94% |
| December 31, 2025 | 27.44% |
| September 30, 2025 | 39.21% |
| June 30, 2025 | 27.75% |
| March 31, 2025 | 19.79% |
| December 31, 2024 | 23.58% |
| September 30, 2024 | 16.64% |
| June 30, 2024 | 23.23% |
| March 31, 2024 | -62.37% |
| December 31, 2023 | 19.94% |
| September 30, 2023 | 30.87% |
| June 30, 2023 | 15.77% |
| March 31, 2023 | 15.57% |
| December 31, 2022 | 22.35% |
| September 30, 2022 | 25.54% |
| June 30, 2022 | 18.26% |
| March 31, 2022 | 0.18% |
| December 31, 2021 | 5.19% |
| September 30, 2021 | 34.75% |
| June 30, 2021 | 24.31% |
| March 31, 2021 | 26.71% |
| December 31, 2020 | 20.78% |
| September 30, 2020 | 5.38% |
| June 30, 2020 | -65.29% |
| Date | Value |
|---|---|
| March 31, 2020 | 27.86% |
| December 31, 2019 | 45.98% |
| September 30, 2019 | -20.96% |
| June 30, 2019 | 33.19% |
| March 31, 2019 | 37.47% |
| December 31, 2018 | 0.05% |
| September 30, 2018 | 37.46% |
| June 30, 2018 | 31.95% |
| March 31, 2018 | 29.96% |
| December 31, 2017 | -64.14% |
| September 30, 2017 | 41.48% |
| June 30, 2017 | 43.06% |
| March 31, 2017 | 41.77% |
| December 31, 2016 | 42.37% |
| September 30, 2016 | 44.28% |
| June 30, 2016 | 44.91% |
| March 31, 2016 | 46.28% |
| December 31, 2015 | 55.95% |
| September 30, 2015 | 56.29% |
| June 30, 2015 | 55.81% |
| March 31, 2015 | 58.16% |
| December 31, 2014 | 47.60% |
| September 30, 2014 | 45.08% |
| June 30, 2014 | 55.70% |
| March 31, 2014 | 44.28% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 21.21% |
| Amgen, Inc. | 23.59% |
| Vertex Pharmaceuticals, Inc. | 32.89% |
| Biogen, Inc. | 3.72% |
| Regeneron Pharmaceuticals, Inc. | 30.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.39% |
| Return on Assets | -5.81% |
| Return on Invested Capital | -7.27% |
| Gross Profit Margin (Quarterly) | 79.81% |
| Operating Margin (Quarterly) | 33.83% |
| Return on Net Operating Assets | -8.57% |